Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp
Get in touch

Keep Yourself Healthy And Fit With Right Medicine.

"Our Only Priority is to keep You Healthy"

Search Result For : cufsn

Search Result For : tablet
Cufsniff AM Junior Syrup Ambroxol (10mg/5ml) + Guaifenesin (25mg/5ml) + Terbutaline (0.5mg/5ml)
Cufsniff AD Syrup Dextromethorphan Hydrobromide I.P. 10mg + Ambroxol HCL I.P. 15mg + Chlorpheniramine Maleate I.P. 2mg + Phenylephrine HCL I.P. 5mg + Menthol I.P. 1.5mg
Cufsniff AL Syrup Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Levocetirizine (2.5mg/5ml) + Menthol (1mg/5ml)
Cufsniff AM Syrup Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml)
Cufsniff M Tablet Ambroxol (15mg) + Guaifenesin (50mg) + Terbutaline (2.5mg) Tablet
Cufsniff 30 Syrup Ambroxol (30mg/5ml) Syrup
Cufsniff AD Tablet Ambroxol (30mg) + Cetirizine (5mg) + Dextromethorphan Hydrobromide (10mg) + Guaifenesin (100mg) + Phenylephrine (15mg)
Cufsniff AM Drop Ambroxol (7.5mg) + Guaifenesin (12.5mg) + Terbutaline (0.25mg)
Cufsniff LS Drop Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)
Cufsniff 15 Respules Ambroxol Hydrochloride 15 mg Respule
Cufsniff NP Junior Syrup Ammonium Chloride (7mg/5ml) + Noscapine (1.83mg/5ml) + Sodium Citrate (0.67mg/5ml) Syrup
Cufsniff BR Plus Syrup Bromhexine (4mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (0.5mg/5ml) + Terbutaline (1.25mg/5ml) Syrup
Cufsniff LD Syrup Chlorpheniramine Maleate (2mg/5ml) + Levodropropizine (30mg/5ml)
Cufsniff DM Syrup Chlorpheniramine maleate 2 mg + Dextromethorphan 10 mg syrup
Cufsniff DP Syrup Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (5mg/5ml) Syrup
Cufsniff DP Syrup Dextromethorphan 5 mg + Chlorpheniramine 2 mg Syrup
Cufsniff DX Syrup Dextromethorphan Hydrobromide I.P. 10mg + Chlorpheniramine Maleate I.P. 2mg + Phenylephrine HCL I.P. 5mg Syrup
Cufsniff G Syrup Dextromethorphan Hydrobromide I.P. 5mg + Chlorpheniramine Maleate I.P. 2.5mg + Guaiphenesin I.P. 50mg + Ammonium Chloride I.P. 60mg
Cufsniff 25 Capsule Diphenhydramine (25mg) Capsule
Cufsniff DR Syrup Diphenhydramine HCL I.P. 14.08mg + Ammonium Chloride I.P. 138.00mg + Sodium Citrate I.P. 57.03mg
Cufsniff LR Syrup Levocloperastine (20mg/5ml) + Chlorpheniramine Maleate (4mg/5ml) Syrup
Cufsniff LP Syrup Levocloperastine (20mg/5ml) Syrup
Cufsniff LD Syrup Levodropropizine I.P. 30mg + Chlorpheniramine I.P. 2mg syrup
Cufsniff LS Drop Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)
Cufsniff LS Junior Syrup Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml)
Cufsniff LS Junior Syrup Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Cufsniff LS Syrup Levosalbutamol (1mg/5ml) + Ambroxol (30mg/5ml) + Guaifenesin (50mg/5ml)
Cufsniff Dx Junior Syrup Phenylephrine (2.5mg/5ml) + Chlorpheniramine Maleate (1mg/5ml) + Dextromethorphan Hydrobromide (5mg/5ml)
Cufsniff SG Softgel Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Cufsniff DX Syrup Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Cufsniff DMR Tablet Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Cufsniff Injection Chlorpheniramine Maleate (10mg) Injection
Cufsniff BR Syrup Terbutaline Sulphate I.P. 1.25mg + Bromhexine HCL I.P. 2mg + Guaiphenesin I.P. 50mg + Menthol I.P. 0.5mg
Cafoli Rub Balm Vaporizing Balm

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Call Now
Whatsapp

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.